Possible prevention of hungry bone syndrome following parathyroidectomy by preoperative use of pamidronate.
Gurevich
Yuriy
Y
Division of Endocrinology and Metabolism, Department of Medicine, Beth Israel Medical Center and Albert Einstein College of Medicine, New York, NY 10003, USA. ygurevic@chpnet.org
Poretsky
Leonid
L
D000236:Adenoma / Q000097:blood / Q000601:surgery; D000368:Aged; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000150:complications* / Q000209:etiology; D000077268:Pamidronate; D010282:Parathyroid Neoplasms / Q000097:blood / Q000601:surgery; D016105:Parathyroidectomy / Q000009:adverse effects*; D013577:Syndrome
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000077268:Pamidronate